Nuo Therapeutics, Inc. (AURX)

Nuo Therapeutics Revenue

In the year 2025, Nuo Therapeutics had annual revenue of $3.31M with 142.72% growth. Nuo Therapeutics had revenue of $1.10M in the quarter ending December 31, 2025, with 177.77% growth.

• Revenue: 3.31M
• Revenue Growth: +142.72%
• P/S Ratio: 17.53
• Revenue / Employee: 331.35K
• Employees: 10
• Market Cap: 58.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.31M	1.95M	142.72%
Dec 31, 2024	1.37M	756.65K	124.34%
Dec 31, 2023	608.53K	496.28K	442.12%
Dec 31, 2022	112.25K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error